Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-03
1999-08-31
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548578, 548579, A61K 3140, C07D20706
Patent
active
059454431
ABSTRACT:
Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided. The compound of formulae IV having the structure: ##STR1## wherein X.sub.9 ;
REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
Raynor et al., Molecular Pharmacol., 45: 330-334 (1994).
Wheeler-Aceto et al., Psychopharmacology, 104: 35-44 (1991).
Chang An-Chih
DeHaven-Hudkins Diane L.
Farrar John J.
Gaul Forrest
Kruse Lawrence I.
Adolor Corporation
Balogh Imre
McKane Joseph K.
LandOfFree
Kappa agonist compounds and pharmaceutical formulations thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist compounds and pharmaceutical formulations thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist compounds and pharmaceutical formulations thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426604